Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 3/20 | 0.56 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.47 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | DRD1 | P21728 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | HTR6 | P50406 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31649956 | 1.00 | TRPV4 (0.56) | TRPV4SLC22A12PTGES2ELANEDRD1 | |
| SCHEMBL16835445 | 0.85 | TRPV4 (0.45) | TRPV4SLC22A12PTGES2ELANEKMT2A | |
| SCHEMBL13692615 | 0.82 | TRPV4 (0.50) | TRPV4SLC22A12PTGES2ELANEDRD1 | |
| SCHEMBL1500968 | 0.81 | IRAK4 (0.44) | TRPV4PTGES2ELANEALDH1A1HSD17B10 | |
| SCHEMBL113890 | 0.81 | SLC22A12 (0.47) | TRPV4SLC22A12PTGES2ELANEDRD1 | |
| SCHEMBL31315370 | 0.81 | PTGES2 (0.55) | TRPV4SLC22A12PTGES2ELANEDRD1 | |
| SCHEMBL1622136 | 0.81 | PTGES2 (0.55) | TRPV4SLC22A12PTGES2ELANEDRD1 | |
| SCHEMBL10780900 | 0.81 | SLC22A12 (0.47) | TRPV4SLC22A12PTGES2ELANEDRD1 | |
| SCHEMBL646910 | 0.79 | TRPV4 (0.47) | TRPV4SLC22A12PTGES2ELANEMAPT | |
| SCHEMBL22954617 | 0.78 | HTR6 (0.61) | TRPV4SLC22A12PTGES2ELANEDRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0064322-B1 | BENZENESULFONYL ISOCYANATES, ISOTHIOCYANATES, CHLORIDES, AND SULFONAMIDES HAVING A FLUORINATED SUBSTITUENT | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-05-22 | — | — | EP | claimed |
| EP-0064322-A2 | Benzenesulfonyl isocyanates, isothiocyanates, chlorides, and sulfonamides having a fluorinated substituent | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-11-10 | — | — | EP | claimed |
| CN-113795307-A | Pyridopyrimidinyl compounds and methods of use thereof | 基因泰克公司 | 2021-12-14 | — | — | CN | disclosed |
| US-10889555-B2 | Sulfonamide compound or salt thereof | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2021-01-12 | — | — | US | disclosed |
| US-20200405697-A1 | Antitumor Agent | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2020-12-31 | — | — | US | disclosed |
| US-20200399235-A1 | Sulfonamide Compound or Salt Thereof | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2020-12-24 | — | — | US | disclosed |
| EP-3728194-A1 | QUINOLINE SULFONAMIDE COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS | Otago Innovation Limited (NZ) | 2020-10-28 | — | — | EP | disclosed |
| EP-3718545-A1 | ANTITUMOR AGENT | Taiho Pharmaceutical Co., Ltd. (JP) | 2020-10-07 | — | — | EP | disclosed |
| US-20200157066-A1 | Sulfonamide Compound or Salt Thereof | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2020-05-21 | — | — | US | disclosed |
| EP-3466934-A1 | SULFONAMIDE COMPOUND OR SALT THEREOF | Taiho Pharmaceutical Co., Ltd. (JP) | 2019-04-10 | — | — | EP | disclosed |
| WO-2017209155-A1 | SULFONAMIDE COMPOUND OR SALT THEREOF | 大鵬薬品工業株式会社 | 2017-12-07 | — | — | WO | disclosed |
| US-4521597-A | PLANT GROWTH REGULATORS | CIBA GEIGY CORPORATION (US) | 1985-06-04 | — | — | US | disclosed |
| US-4518776-A | VIA A SULFONYLCARBAMATE INTERMEDIATE, WITH AN AMINOTRIAZINE OR PYRIMIDINE | CIBA GEIGY CORPORATION (US) | 1985-05-21 | — | — | US | disclosed |
| EP-0121082-A1 | Guanidin derivatives | BAYER AG (DE) | 1984-10-10 | — | — | EP | disclosed |
| US-4476321-A | HERBICIDES, PLANT GROWTH REGULATORS | CIBA-GEIGY CORPORATION (US) | 1984-10-09 | — | — | US | disclosed |
| EP-0107624-A1 | Process for the production of herbicidal and plant growth regulating sulfonyl ureas | CIBA-GEIGY AG (CH) | 1984-05-02 | — | — | EP | disclosed |
| EP-0101407-A2 | Process for the preparation of herbicidal and plant growth regulating sulfonyl urea and sulfonyl carbamates as intermediates | CIBA-GEIGY AG (CH) | 1984-02-22 | — | — | EP | disclosed |
| EP-0044809-B1 | N-(2-SUBSTITUTED PHENYLSULFONYL)-N'-TRIAZINYL UREAS | CIBA-GEIGY AG (CH) | 1983-08-31 | — | — | EP | disclosed |
| EP-0044808-A2 | N-phenylsulfonyl-N'-pyrimidinyl- and -triazinyl ureas | CIBA-GEIGY AG (CH) | 1982-01-27 | — | — | EP | disclosed |
| EP-0044809-A1 | N-(2-substituted phenylsulfonyl)-N'-triazinyl ureas | CIBA-GEIGY AG (CH) | 1982-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200399235-A1 | Sulfonamide Compound or Salt Thereof | RNASEH1, SNRPA1, RRM2 | TRPV4 1831/4885SLC22A12 456/4885PTGES2 4338/4885 |
| US-20200157066-A1 | Sulfonamide Compound or Salt Thereof | RNASEH1, SNRPA1, RRM2 | TRPV4 1831/4885SLC22A12 456/4885PTGES2 4338/4885 |
| US-10889555-B2 | Sulfonamide compound or salt thereof | RNASEH1, SNRPA1, RRM2 | TRPV4 1831/4885SLC22A12 456/4885PTGES2 4338/4885 |
| US-20200405697-A1 | Antitumor Agent | HNRNPR, RRM2, RRM2B | TRPV4 3337/4885SLC22A12 568/4885PTGES2 4378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.